Share on LinkedInShare on LinkedIn

ARTICLE · 05 SEPTEMBER 2024

Market Intelligence Thought Leadership Award Winner

The Future Is Irish? Illumina/Grail & Irish Merger Control Powers

An important ruling of the Court of Justice of the European Union (CJEU) on 3 September 2024, in two cases brought by Illumina and Grail against the European Commission (EC), has essentially held...

IrelandCorporate/Commercial Law

An important ruling of the Court of Justice of the European Union (CJEU) on 3 September 2024, in two cases brought by Illumina and Grail against the European Commission (EC), has essentially held that a company's right to legal certainty places a limit on the EC's most flexible merger control powers. The relevant powers, under Art. 22 of the EU Merger Regulation (EUMR), have been invoked over the last 3 years at the 'new frontiers' of EU enforcement against suspected 'killer acquisitions' of companies which do not meet merger control turnover thresholds.

This is a valuable CJEU ruling for companies engaged in M&A in the EU. It may however result in the Irish Competition Authority (CCPC) having a bigger role in global merger control and specifically in helping the EC review suspected 'killer acquisitions' involving Irish-based pharma and tech companies in particular. We explain why below-

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from